Long-term outcomes with nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinoma.
Journal for immunotherapy of cancer（2022）
摘要
NCT02231749.
更多查看译文
关键词
CTLA-4 Antigen,Drug Therapy, Combination,Immunotherapy,Programmed Cell Death 1 Receptor
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要